New Diagnostic Method for Chagas Disease
Author Information
Author(s): Gretchen Cooley, Drew R. Etheridge, Courtney Boehlke, Becky Bundy, D. Brent Weatherly, Todd Minning, Matthew Haney, Miriam Postan, Susana Laucella, Rick L. Tarleton
Primary Institution: University of Georgia
Hypothesis
Can a multiplex diagnostic panel improve the detection of Trypanosoma cruzi infection compared to conventional serological tests?
Conclusion
The study developed a multiplex diagnostic panel that successfully detected 100% of confirmed positive cases of Chagas disease and improved monitoring of treatment efficacy.
Supporting Evidence
- The multiplex assay detected 100% of >100 confirmed positive sera.
- The diagnostic panel was useful for monitoring drug treatment efficacy in chronic Chagas disease.
- 18 of 33 subjects judged as negative by conventional serology were found to be positive using the multiplex assay.
Takeaway
Scientists created a new test that can find a disease called Chagas better than old tests, helping doctors know who is sick and if treatment is working.
Methodology
The study screened over 400 recombinant proteins from T. cruzi to identify those that effectively detect antibodies in infected individuals.
Limitations
The study did not address the potential variability of the diagnostic proteins across different T. cruzi strains.
Participant Demographics
Participants included adults aged 29 to 61 from endemic areas in Argentina.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website